Alimta Approved as Maintenance Therapy for Advanced Lung Cancer – US News and World Report

The drug Alimta (pemetrexed) has been approved by the U.S. Food and Drug Administration to prevent progression of certain types of advanced or metastatic (spreading) lung cancer, the agency said Monday.